Production (Stage)
Pacific Biosciences of California, Inc.
PACB
$1.14
$0.1414.00%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 343.11M | 783.86M | 471.15M | 509.80M | 561.91M |
| Total Receivables | 31.65M | 27.52M | 29.38M | 32.43M | 30.32M |
| Inventory | 54.01M | 58.76M | 65.74M | 68.59M | 67.34M |
| Prepaid Expenses | 15.47M | 14.78M | 17.28M | 16.97M | 17.14M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 690.00K | 5.38M | 690.00K | 342.00K | 300.00K |
| Total Current Assets | 444.92M | 495.68M | 584.23M | 628.14M | 677.02M |
|
|
|||||
| Total Current Assets | 444.92M | 495.68M | 584.23M | 628.14M | 677.02M |
| Net Property, Plant & Equipment | 69.20M | 46.60M | 49.30M | 57.30M | 67.96M |
| Long-term Investments | 317.76M | 317.76M | 369.06M | 369.06M | 462.26M |
| Goodwill | 317.76M | 317.76M | 369.06M | 369.06M | 462.26M |
| Total Other Intangibles | 18.18M | 389.57M | 436.43M | 443.28M | 450.13M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 10.72M | 13.67M | 11.04M | 11.71M | 12.54M |
| Total Assets | 860.79M | 1.26B | 1.45B | 1.51B | 1.67B |
|
|
|||||
| Total Accounts Payable | 14.04M | 16.59M | 12.06M | 17.49M | 21.01M |
| Total Accrued Expenses | 23.48M | 21.51M | 19.18M | 22.46M | 21.99M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.42M | 10.03M | 10.68M | 12.49M | 9.92M |
| Total Finance Division Other Current Liabilities | 23.67M | 18.17M | 18.08M | 25.96M | 20.03M |
| Total Other Current Liabilities | 23.67M | 18.17M | 18.08M | 25.96M | 20.03M |
| Total Current Liabilities | 66.60M | 66.30M | 60.00M | 78.39M | 72.95M |
|
|
|||||
| Total Current Liabilities | 66.60M | 66.30M | 60.00M | 78.39M | 72.95M |
| Long-Term Debt | 646.21M | 647.49M | 893.14M | 892.84M | 892.55M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 50.48M | 14.91M | 16.93M | 19.62M | 29.05M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 5.86M | 25.15M | 26.86M | 25.94M | 26.36M |
| Total Liabilities | 769.15M | 753.85M | 996.93M | 1.02B | 1.02B |
|
|
|||||
| Common Stock & APIC | 2.67B | 2.66B | 2.60B | 2.58B | 2.57B |
| Retained Earnings | -2.58B | -2.15B | -2.15B | -2.09B | -1.92B |
| Treasury Stock & Other | 381.00K | 422.00K | 1.55M | -523.00K | -306.00K |
| Total Common Equity | 91.64M | 506.59M | 453.12M | 492.70M | 649.02M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 91.64M | 506.59M | 453.12M | 492.70M | 649.02M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 91.64M | 506.59M | 453.12M | 492.70M | 649.02M |
|
|
|||||